Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Caterpillar Inc (CAT)

Caterpillar Inc (CAT)
305.91 +10.14 (+3.43%) 12:51 ET [NYSE]
305.78 x 10 306.10 x 100
Realtime by (Cboe BZX)
305.78 x 10 306.10 x 100
Realtime 297.00 +1.23 (+0.42%) 09:21 ET
News & Headlines for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Here's Why Caterpillar Stock Is Having a Tough Day

Shares in Caterpillar (NYSE: CAT) were down by 3% in today's trading at 3:20 p.m. ET. The decline comes on a bad day for the markets overall and, more importantly, for the commodities that drive orders...

NFLX : 1,095.00 (+4.33%)
CAT : 305.91 (+3.43%)
Stocks Stumble Amid Trump-Fed Conflict

Canada's main stock index opened lower on Monday, dragged by losses in energy shares, while U.S. President ...

CAT : 305.91 (+3.43%)
1 Cash-Producing Stock with Exciting Potential and 2 to Turn Down

1 Cash-Producing Stock with Exciting Potential and 2 to Turn Down

WWW : 12.80 (+3.56%)
ARRY : 4.49 (+3.70%)
CAT : 305.91 (+3.43%)
CAT Vs DE: Which Heavy Machinery Stock is the Better Bet Now?

Caterpillar Inc. CAT and Deere & Company DE are two of the world’s leading heavy equipment manufacturers. Caterpillar, widely recognized by its signature yellow machines, manufactures construction and...

DE : 464.82 (+1.84%)
CAT : 305.91 (+3.43%)
Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar

The US dollar has been falling since the beginning of 2025 down over 6% by April, which makes American products cheaper for overseas buyers helping boost demand

UUP : 27.35 (-0.33%)
AAPL : 206.10 (+0.73%)
KO : 72.87 (-0.59%)
CAT : 305.91 (+3.43%)
COKE : 1,403.18 (+0.76%)
TOROMONT TO ANNOUNCE FIRST QUARTER 2025 RESULTS ON APRIL 30, 2025 AND HOLD ANNUAL GENERAL MEETING OF SHAREHOLDERS ON MAY 1, 2025

/CNW/ - Toromont Industries Ltd. (TSX: TIH) will release its first quarter 2025 results after markets close on April 30, 2025. Analysts, members of the media...

CAT : 305.91 (+3.43%)
TIH.TO : 115.66 (+0.95%)
Caterpillar Promotes COO Joseph Creed As Chief Executive, CEO Umpleby To Become Executive Chairman Of Board

Joseph Creed’s promotion comes less than a year after he was named COO as part of the company’s broader succession plan.

XLI : 128.57 (+1.89%)
CAT : 305.91 (+3.43%)
QUAL : 166.27 (+1.59%)
NYSE Content Advisory: Pre-Market update + Bank of America beats earnings estimates

/CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for...

C : 67.88 (+2.38%)
BAC : 39.61 (+2.22%)
PNC : 159.56 (+1.37%)
F : 10.05 (+2.76%)
GM : 46.77 (+2.03%)
CAT : 305.91 (+3.43%)
JNJ : 154.38 (-0.64%)
AXS : 95.01 (-0.06%)
Construction Machinery Q4 Earnings: Astec (NASDAQ:ASTE) is the Best in the Biz

Construction Machinery Q4 Earnings: Astec (NASDAQ:ASTE) is the Best in the Biz

MTW : 8.01 (+3.76%)
TEX : 35.88 (+4.09%)
CAT : 305.91 (+3.43%)
ASTE : 35.16 (+2.57%)
Marjorie Taylor Greene Buys Major Tech Stocks Ahead of Trump’s Tariff Pause as AOC Argues: ‘It’s Time to Ban Insider Trading in Congress’

Rep. Marjorie Taylor Greene is under scrutiny for timely stock purchases in tech and logistics companies that stand to benefit from President Donald Trump’s temporary tariff rollbacks.

AAPL : 206.10 (+0.73%)
JPM : 243.78 (+1.20%)
NKE : 58.08 (+1.20%)
LULU : 271.38 (+2.08%)
QCOM : 146.84 (+4.54%)
CAT : 305.91 (+3.43%)
LRCX : 70.49 (+5.63%)
PI : 90.33 (+17.21%)
FDX : 213.18 (+1.01%)
SO : 91.29 (+0.18%)
DELL : 93.30 (+4.64%)
AMZN : 185.15 (+2.52%)
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

MYGN : 7.30 (+0.14%)
Why Myriad Genetics (MYGN) Shares Are Plunging Today

Why Myriad Genetics (MYGN) Shares Are Plunging Today

MYGN : 7.30 (+0.14%)
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

SRPT : 61.33 (+3.09%)
MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
UTHR : 296.69 (+1.10%)
Myriad: Q4 Earnings Snapshot

Myriad: Q4 Earnings Snapshot

MYGN : 7.30 (+0.14%)
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

MYGN : 7.30 (+0.14%)
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

MYGN : 7.30 (+0.14%)
Myriad Genetics Announces Senior Leadership Transition

MYGN : 7.30 (+0.14%)
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

MYGN : 7.30 (+0.14%)
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

MYGN : 7.30 (+0.14%)
Why Myriad Genetics (MYGN) Shares Are Plunging Today

Why Myriad Genetics (MYGN) Shares Are Plunging Today

MYGN : 7.30 (+0.14%)
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

SRPT : 61.33 (+3.09%)
MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
UTHR : 296.69 (+1.10%)
Myriad: Q4 Earnings Snapshot

Myriad: Q4 Earnings Snapshot

MYGN : 7.30 (+0.14%)
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

MYGN : 7.30 (+0.14%)
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

MYGN : 7.30 (+0.14%)
Myriad Genetics Announces Senior Leadership Transition

MYGN : 7.30 (+0.14%)
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

MYGN : 7.30 (+0.14%)
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

MYGN : 7.30 (+0.14%)
Why Myriad Genetics (MYGN) Shares Are Plunging Today

Why Myriad Genetics (MYGN) Shares Are Plunging Today

MYGN : 7.30 (+0.14%)
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

SRPT : 61.33 (+3.09%)
MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
UTHR : 296.69 (+1.10%)
Myriad: Q4 Earnings Snapshot

Myriad: Q4 Earnings Snapshot

MYGN : 7.30 (+0.14%)
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

MYGN : 7.30 (+0.14%)
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

MYGN : 7.30 (+0.14%)
Myriad Genetics Announces Senior Leadership Transition

MYGN : 7.30 (+0.14%)
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

MYGN : 7.30 (+0.14%)
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)

Barchart Exclusives

European Commodities: Cocoa Prices Stay Hot Amid Continued Supply Challenges
Here are the European commodity winners and losers over the past week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.